행사/교육
The 13th Annual BIO CEO & Investor Conference
- 등록일2010-11-10
- 조회수2468
- 구분 국외
- 행사교육분류 행사
-
주관기관
BIOTECHNOLOGY INDUSTRY ORGANIZATION
-
행사장소
Waldorf=Astoria, New York City
-
행사기간
2011-02-14 ~ 2011-02-15
- 원문링크
-
첨부파일
The 13th Annual BIO CEO & Investor Conference
An International Biotechnology Investor Conference Featuring Established & Emerging Public Companies
- February 14-15, 2011
- Waldorf=Astoria, New York City
The BIO CEO & Investor Conference is the largest investor conference focused on publicly traded biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.
Our therapeutic workshops feature the latest information on pipeline innovation, and no other investor conference offers as many sessions involving MDs, CSOs, and industry analysts.
BIO One-on-One Partnering also provides an opportunity to arrange meetings between investors; companies; and industry BD, licensing and therapeutic franchise heads.
More information
Now in its thirteenth year, the BIO CEO & Investor Conference is the largest independent investor conference focused on publicly-traded biotechnology companies.
Who Shouldn't Miss This Conference
- Institutional Investors
- Industry Analysts
- Senior Biotechnology Executives
Program
Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.
The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.
Why Investors Attend:
- Hear from and meet one-on-one with management from the top biotechnology companies
- Evaluate fresh investment opportunities including compatible, complementary and
competitive companies
- Attend candid panel discussions with leading clinical experts and company experts on the
latest therapies and technologies in development
- Get a ‘big picture’ overview of the industry and the issues affecting investments now and in
the future
Why Companies Attend:
- Present company story to an audience of target investors
- Meet one-on-one with new and current investors, analysts, investment bankers and other
potential corporate partners
- Hear candid panel discussions and keynotes by veteran investment and company
executives
- Network with peers, investors and potential partners attending the conference
- Get the pulse on the current and proposed investment trends in biotechnology
2011 Advisory Committee:
Hany Awadalla Managing Director Rodman & Renshaw, LLC.
Ron Cohen President & Chief Executive Officer Acorda Therapeutics
John Crowley President & Chief Executive Officer Amicus Therapeutics
Don DeBethizy President & Chief Executive Officer Targacept, Inc.
David Farhadi Vice President & Portfolio Manager Fred Alger Management
Annette Grimaldi Managing Director BMO Capital Markets
Thomas Okarma President & Chief Executive Officer Geron Corporation
Chris Swindle Managing Director Wedbush PacGrow Life Sciences
For more information, please contact BIO CEO customer service:
Email: biopartnering@bio.org
Phone: 866.356.5155, +1.202.962.6666
......(계속)
☞ 자세한 내용은 내용바로가기를 이용하시기 바랍니다.